Demand access to third COVID-19 vaccination for immunocompromised people

Did you know that there is strong scientific evidence that people diagnosed with IBD who are on therapies that suppress their immune system can lose their immunity to COVID-19 acquired by the vaccines?

That’s why our COVID-19 and IBD Task Force and most recently NACI recommends that people with IBD who are systemically immunosuppressed (using medications like systemic corticosteroids, thiopurines, methotrexate, or biologics) have access to a third COVID-19 vaccination 14–18 weeks after their second  dose.

Thank you to Quebec, BC, Ontario, and PEI for including this community in their recommendations for a third COVID-19 vaccination.

You can help encourage other provinces to do the same by sending a letter to your local government representatives.

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.